相关实验视频
Updated: Jul 20, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
老年人肥胖的全球流行:一个元分析
Ali Asghar Khaleghi1, Nader Salari2, Niloofar Darvishi3
1Department of Emergency Medicine, Faculty of Medicine, Fasa University of Medical Sciences and Health Services, Fars, Iran.
Public health in practice (Oxford, England)
|February 4, 2025
概括
肥胖影响全球25.3%的老年人. 卫生政策制定者必须提高对这一人口群体肥胖风险的认识,以解决这一日益严重的公共卫生问题.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 肥胖,定义为过度的身体脂肪积累,是一个重要的全球健康挑战.
- 它不成比例地影响着各种人群,包括老年人.
- 了解老年人肥胖的患病率对于有针对性的公共卫生干预至关重要.
研究的目的:
- 调查全球老年人中肥胖的流行情况.
- 为了确定这一人口群体中肥胖率的区域差异.
- 分析与研究特征相关的肥胖流行趋势.
主要方法:
- 全球44项涉及45745944名老年人的研究的系统审查和元分析.
- 在主要数据库 (PubMed,Scopus,Web of Science等) 进行了搜索. 在2020年8月之前.
- 肥胖症被定义为身体质量指数 (BMI) ≥30. 随机效应模型用于分析.
主要成果:
- 在老年人中,肥胖的全球患病率为25.3% (95%CI:21.9-29).
- 南美洲报告的患病率最高,为40.4% (95%CI:12.5-76.4),其次是欧洲大陆,为33.6% (95%CI:24.1-44.5).
- 超回归表明,随着更大的样本大小,肥胖患病率的趋势越来越大,随着研究持续时间的增长趋势下降.
结论:
- 老年人中肥胖的高患病率需要紧急的公共卫生行动.
- 卫生政策制定者应该优先考虑提高对这个年龄组肥胖相关风险的认识的举措.
- 需要进一步的研究和有针对性的干预措施,以减轻肥胖对老年人口的影响.
相关概念视频
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...